Eli Lilly is planning to launch their diabetes and weight loss drug called Mounjaro in India next year. India has a large number of diabetic and obese people, presenting a booming market for the company. While India already has generic drug makers who are trying to create the drug for a more affordable price, the question stands: Is India ready for it?